RECRUITING

A Long-term Extension Study of JNJ-81201887 (AAVCAGsCD59) Parent Studies in Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD)

Talk to us

Conditions

Geographic AtrophyMacular Degeneration

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

The purpose of this study is to assess the long-term safety and tolerability after an intravitreal injection (a shot of medicine into the eye) of JNJ-81201887 administered in parent clinical studies.

Official Title

Long-term Extension Study for Participants With Geographic Atrophy (GA) Secondary to Age-related Macular Degeneration (AMD) in JNJ-81201887 Parent Clinical Studies

Quick Facts

Study Start:2024-09-19
Study Completion:2029-12-03
Study Type:Not specified
Phase:Not Applicable
Enrollment:Not specified
Status:RECRUITING

Study ID

NCT06635148

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:60 Years
Sexes Eligible for Study:ALL
Accepts Healthy Volunteers:No
Standard Ages:ADULT, OLDER_ADULT
Inclusion CriteriaExclusion Criteria
  1. * Participants who were enrolled and received treatment with JNJ-81201887 or sham in a parent clinical study (81201887MDG2001, 81201887MDG1003)
  2. * Females (women of childbearing potential), male participants, and partners of male participants will not be required to use contraception in this LTE study
  3. * Must sign an informed consent form (ICF) indicating that participant understands the purpose of, and procedures required for, the study and is willing to participate in the study. The ICF may be signed by an impartial witness and/or legally designated representative depending on national/local regulations
  1. * There are no exclusion criteria for this LTE study

Contacts and Locations

Study Contact

Study Contact
CONTACT
844-434-4210
Participate-In-This-Study@its.jnj.com

Principal Investigator

Janssen Research & Development, LLC Clinical Trial
STUDY_DIRECTOR
Janssen Research & Development, LLC

Study Locations (Sites)

Retina Associates Southwest PC
Tucson, Arizona, 85704
United States
Retina Consultants of Orange County
Fullerton, California, 92835
United States
Bay Area Retina Associates
Walnut Creek, California, 94598
United States
VitreoRetinal Associates, PA
Gainesville, Florida, 32607
United States
Retina Specialty Institute
Pensacola, Florida, 32503
United States
Marietta Eye Clinic
Marietta, Georgia, 30060
United States
Maine Eye Center
Portland, Maine, 04101
United States
Cumberland Valley Retina Consultants
Hagerstown, Maryland, 21740
United States
Foundation for Vision Research
Grand Rapids, Michigan, 49546
United States
The Retina Institute
Saint Louis, Missouri, 63144
United States
Asheville Eye Associates - Western Carolina Retinal Associates
Asheville, North Carolina, 28803
United States
Graystone Eye
Hickory, North Carolina, 28602
United States
Cincinnati Eye Institute
Cincinnati, Ohio, 45242
United States
Erie Retina Research
Erie, Pennsylvania, 16507
United States
Strategic Clinical Research Group
Willow Park, Texas, 76087
United States
Piedmont Eye Center
Lynchburg, Virginia, 24502
United States
Wagner Kapoor Research institute
Norfolk, Virginia, 23502
United States
Spokane Eye Clinical Research
Spokane, Washington, 99204
United States

Collaborators and Investigators

Sponsor: Janssen Research & Development, LLC

  • Janssen Research & Development, LLC Clinical Trial, STUDY_DIRECTOR, Janssen Research & Development, LLC

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-09-19
Study Completion Date2029-12-03

Study Record Updates

Study Start Date2024-09-19
Study Completion Date2029-12-03

Terms related to this study

Additional Relevant MeSH Terms

  • Geographic Atrophy
  • Macular Degeneration